Introduction
Interleukin (IL)-21 is a member of the type I cytokine family and can be secreted by CD4
+ T cells including T follicular helper (Tfh) cells, Th17 cells and natural killer (NK) T cells [
1]. IL-21 signals through the common cytokine receptor γ chain in combination with its functional receptor, IL-21 receptor (R) which is mainly expressed on B cells and also on T cells, NK cells, dendritic cells, epithelial cells and fibroblasts [
2‐
4].
It has been reported that IL-21 is able to enhance the proliferation and effector characteristics of activated CD4
+ and CD8
+ T cells [
5] and limit the differentiation of inducible regulatory T cells [
6‐
8]. IL-21 can also modulate Tfh cell differentiation via the upregulation of Bcl-6, the transcription factor of Tfh cells [
9]. The Tfh cell is a specialized T cell subset, which is characterized by increased expression of molecules, including CXCR5, PD-1, ICOS, CD40L and IL-21 and decreased expression of CCR7 [
10]. Expressing these molecules allows Tfh cell migration into the germinal center (GC) to provide help for B cell growth, differentiation and class switching [
11‐
13]. Reportedly, exposure of CD4
+ T cells to IL-21 drives them to differentiate into a Tfh cell subset partly through modulation of the expression of CXCR5 and CCR7 by IL-21 in an autocrine manner [
14,
15]. Also, Tfh cell regulation of B cell proliferation, differentiation and antibody production is via the secretion of IL-21 [
16‐
18].
Moreover, IL-21 can directly act on B cells. IL-21 co-stimulation is capable of promoting plasma cells differentiation from CD27
+ memory B cells, inducing class switch recombination and stimulating poorly responsive naive cord blood B cells into IgG-secreting plasma cells in humans [
11]. In addition, antigen-specific memory B cells and plasma cells fail to expand and IgG production is significantly impaired following secondary immunization of IL-21R.KO mice [
19]. Furthermore, IL-21 acts in a B cell-intrinsic fashion to control GC formation [
9]. The absence of IL-21 signaling profoundly affects GC persistence and function, influencing its proliferation, transition into memory B cells, and affinity maturation [
20]. Thus, the effect of IL-21 on B cells may contribute to the development of autoimmune diseases.
Rheumatoid arthritis (RA) is characterized by persistent synovitis and systemic inflammation, frequently leading to cartilage and bone destruction. Although the etiology and pathology remain elusive, auto-antibodies to citrullinated cyclic peptides (CCP) and rheumatoid factor (RF) have been indicated to be associated with the disease course [
21‐
25]. When transferring auto-antibodies to mice with certain genetic backgrounds, they may provoke articular inflammation [
26,
27]. Importantly, B cells are the primary source of RF and anti-CCP auto-antibodies and Tfh cells assist B cells, suggesting a critical role of Tfh and B cells in the pathogenesis of RA. Recent studies observe that IL-21R transcript is expressed by synovial macrophages and fibroblasts from RA patients but not from patients with osteoarthritis (OA) [
28] and IL-21R deficiency in the K/BxN mouse model of inflammatory arthritis is sufficient to protect it from arthritis [
29]. However, the effect of IL-21 regulation on Tfh and B cells in the pathogenesis of RA remains largely unknown.
In this report, we investigated the function of IL-21 on Tfh-like cells and B cells in RA. Our data showed that increased serum IL-21 levels in RA patients correlated positively with 28-joint count disease activity score (DAS28), serum anti-CCP antibodies and frequencies of Tfh-like cells. IL-21 supported B cell activation, proliferation and antibody secretion. Strikingly, blockade of IL-21R markedly inhibited the impact of IL-21 on B cells in RA patients.
Materials and methods
Patients and controls
Serum samples were collected from active RA patients (
n = 120) admitted to the ward of The Affiliated Drum Tower Hospital of Nanjing Medical University, from July 2010 to September 2012. All patients fulfilled the American College of Rheumatology criteria for the classification of RA and they had no other autoimmune or systemic diseases. None of these patients was pregnant or menopausal at the time of the study. Age- and sex-matched healthy controls (HC,
n = 80) were obtained from the medical examination center. Serum samples were stored at -80°C until used. The study protocol was approved by the ethics committee of The Affiliated Drum Tower Hospital of Nanjing Medical University. Written informed consents were obtained from all patients and controls. Detailed clinical characteristics and laboratory features are shown in Table
1.
Table 1
Clinical and laboratory features in 120 patients with rheumatoid arthritis (RA)
Age, yrs | 58.95 ± 1.12 |
Men/women | 33/87 |
Disease duration, yrs | 18.02 ± 8.98 |
DAS28 | 4.89 ± 0.09 |
ESR, mm/h | 60.86 ± 2.60 |
CRP, mg/l | 38.71 ± 4.03 |
RF-IgM-positive | 89 (74.17) |
RF-IgG-positive | 66 (55.00) |
RF-IgA-positive | 72 (60.00) |
Anti-CCP-positive | 65 (54.17) |
Treatment | |
DMARDs | 9 (7.50) |
CS | 22 (18.33) |
CS+DMARDs | 41 (34.17) |
Others | 48 (40.00) |
Enzyme-linked immunosorbent assay (ELISA) for serum IL-21 levels
Serum IL-21 levels in RA patients and HC were measured by human IL-21 ELISA kits (Biolegend, San Diego, CA, USA) according to the instructions of the manufacturer. The plate was read at 450 nm and sensitivity of the ELISA kits used in the experiment was 16 pg/ml.
Clinical data and inflammation index analysis
All patients were followed up to obtain clinical data on age, sex, disease duration, number of swollen and tender joints, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), anti-CCP antibodies, RF-IgM, RF-IgG and RF-IgA.
ESR was evaluated by the Westergren method. Values ≤ 15 mm/h for men and 20 mm/h for women were considered normal. CRP was examined by the immunonephelometry method and a value > 8 mg/l was considered positive. Anti-CCP antibody, RF-IgM, RF-IgG and RF-IgA were tested by ELISA, with normal ranges of 0 to 5 RU/ml for RF-IgM, and 0 to 20 RU/ml for RF-IgG and RF-IgA. The DAS28 was calculated as previously described [
30].
Detection of IL-21R and activation marker expression by flow cytometry
Peripheral blood mononuclear cells (PBMC) were isolated from active RA patients or HC using Ficoll density-gradient centrifugation. The cell suspension was washed three times in phosphate- buffered saline (PBS) and then labeled with the following monoclonal antibodies: phycoerythrin (PE)-conjugated anti-IL21R (R&D Systems, Minneapolis, MN, USA), fluorescein isothiocyanate (FITC)- or allophycocyanin (APC)-conjugated anti-CD19, Pecy7-conjugated anti-CD40, PE-conjugated anti-CD25, FITC-conjugated anti-CD69, FITC-conjugated anti-CD4, APC-conjugated anti-CXCR5 and PerCP-Cy5.5-conjugated anti-PD-1 (BD Biosciences, Franklin Lakes, NJ, USA). For surface marker staining, cells were maintained in the dark at 4°C for 30 minutes and then washed twice in PBS. IL-21R on Tfh-like cells and B cells and activation surface markers expression of B cells were analyzed by flow cytometry.
B cell stimulation by IL-21
PBMC from RA patients or HC were cultured in RPMI 1640 supplemented with 10% fetal calf serum (FCS) and antibiotics (penicillin 100 IU/ml, streptomycin 100 μg/ml; Invitrogen, Camarillo, CA, USA) in a humidified atmosphere of 5% CO2 at 37°C. For the studies of IL-21R and B cell activation, PBMC (1*106/well) were added to 96-well plates directly with or without 100 ng/ml recombinant human IL-21 (Abcam, Cambridge, MA, USA). For proliferation studies, PBMC (1*106/well) were treated with 3 μg/ml anti-CD40 antibody (eBioscience, San Diego, CA, USA), 50 ng/ml rIL-4 (PeproTech Inc, Rocky Hill, NJ, USA) and 100 ng/ml rIL-21 (Abcam). For apoptosis studies, PBMC (1*106/well) were stimulated with 3 μg/ml anti-CD40 antibody (eBioscience), and 100 ng/ml rIL-21 (Abcam). For differentiation to plasmablast studies, PBMC (1*106/well) were treated with 3 μg/ml anti-CD40 antibody (eBioscience), 5 μg/ml F(ab)2 goat anti-human IgM (Jackson ImmunoResearch, West Grove, PA, USA) and 100 ng/ml rIL-21 (Abcam). To investigate the possible mechanism of IL-21, 10 ug/ml anti-IL-21R antibody (Biolegend) was included in cell cultures.
Quantification of cytokines in serum
Serum cytokines were analyzed using Quantibody Human TH17 Array 1 (QAH-TH17-1, RayBiotech, Norcross, GA, USA), according to the manufacturer's specification. Each sample was prepared in triplicate. An Axon scanner 4000B with GenePix software was used to collect fluorescence intensities.
Proliferation and apoptosis assays
PBMC from RA patients and HC were labeled with 5 μM carboxyfluorescein diacetate succinimidyl ester (CFSE) (Invitrogen) in PBS for 10 minutes at 37°C. An excess of ice-cold RPMI 1640 with 10% FCS was added to the cells to quench the reaction and cells were washed extensively. CFSE-labeled cells (1*106/well) were cultured according to above-mentioned methods. Following 4 days of culture, cells were collected and then stained with APC-conjugated anti-CD19 (BD Biosciences). B cell proliferation was determined by flow cytometry analysis of CFSE fluorescence intensity. To detect apoptotic cells, cultured PBMC were collected and resuspended in 100 μl of 1 × binding buffer (10 mM HEPES (pH 7.4), 140 mM NaCl and 2.5 mM CaCl2) and stained with 5 μl of FITC-conjugated Annexin V (BD PharMingen, San Diego, CA, USA) for 15 minutes at room temperature in the dark and then analyzed by flow cytometry.
Determination of immunoglobin (Ig) levels
After 4 days' culture, secreted IgG and IgM in the culture supernatants were quantitated by ELISA (MABTECH, Nacka Strand, Sweden) according to the instructions of the manufacturer. PE-conjugated anti-CD138 (BD Biosciences) expression was analyzed in cultured cells using flow cytometry.
Statistical analysis
Data were summarized as means ± standard error of the mean (SEM). Statistical significance was performed by Student's t-test and the correlation coefficient between serum IL-21 levels and clinical features in RA patients were analyzed by Spearman's rank test. All statistical analyses were performed using GraphPad Prism software (Graph-Pad, San Diego, CA, USA). A P-value < 0.05 was considered significantly different.
Discussion
Previous studies have detected IL-21R at mRNA and protein levels in synovial tissue samples from RA patients [
28,
34], supporting the idea that IL-21/IL-21R is implicated in the pathogenesis of RA. In the present study we showed serum IL-21 levels were significantly increased in RA patients. IL-21 concentrations were positively correlated with anti-CCP antibodies in the high IL-21 group of RA patients, suggesting IL-21 might be involved in auto-antibody production. Moreover, the high IL-21 levels were correlated with DAS28, indicating that IL-21 relates to clinical activity, which is consistent with the study by Rasmussen
et al.[
35].
Tfh cells are a subset of T cells that specialize in providing help for B cells. They are characterized by increased expression of molecules including CXCR5, PD-1, ICOS, CD40L and IL-21, and decreased expression of CCR7 [
10]. Most of the Tfh cells are located in the light zone of GC in secondary lymphoid tissue in human, but it was reported that human blood CD4
+CXCR5
+ T cells also shared functional properties with Tfh cells [
17]. In our study we observed that the frequencies of circulating Tfh-like cells markedly increased in PB from RA patients, suggesting Tfh-like cells might be involved in the pathogenesis of RA. As the function of Tfh cells was assisting B cells to secret antibodies, we next assessed the relationship between Tfh-like cells and anti-CCP antibodies/RF. The results revealed that the high percentages of Tfh-like cells were positively correlated with anti-CCP antibodies but not RF.
Based on the relationship between IL-21 and auto-antibody production, we focused on the role of IL-21 in regulating Tfh-like cells and B cells, two principal cells contributing to antibody secretion. First of all, we found that high IL-21 levels were positively correlated with the frequencies of Tfh-like cells. Furthermore, IL-21R expression on Tfh-like cells was upregulated, confirming that Tfh-like cells are potent responders for IL-21. Reportedly, IL-21 was essential for B cell activation [
36] and was the most potent T cell-derived cytokine to induce B cell proliferation from PB, spleen, and tonsil in humans [
11]. Our study demonstrated that IL-21 was able to directly promote B cell activation
in vitro in RA patients. Moreover, IL-21 induced B cell expansion more significantly in RA patients than in HC. A balance between the proliferation and apoptosis of immune cells is needed to maintain homeostasis of the immune system. In this study, IL-21 had different impacts on the apoptosis of B cells in RA patients and HC. In HC, IL-21 promoted B cell apoptosis. A previous study demonstrated that IL-21 stimulation of murine B cells led to a rapid decrease of anti-apoptotic protein Bcl-2 and Bcl-X
L at mRNA and protein levels [
37], which might be a possible mechanism of our result. However, we did not find the influence of IL-21 on B cell apoptosis in RA patients. Notably, our results have shown that IL-21 stimulation promoted B cell activation and expansion in RA. This discrepancy implicates that IL-21 might be prone to inducing B cell activation and expansion instead of apoptosis in RA.
Ig production is a key component in B cell differentiation and the generation of protective humoral immune responses. Accumulated evidence suggests that IL-21 in combination with CD40L and/or anti-IgM is an inducer of plasma cell differentiation [
11,
38]. Moreover, IL-21 has also been shown to be a critical cytokine that stimulates IgG production compared to IL-2, IL-4 and IL-10 [
11,
38]. We found that IL-21 induced anti-CD40 and anti-IgM-stimulated B cells to differentiate into plasmablasts, and yielded higher levels of IgG and IgM in RA patients compared to HC, although there were no significant differences in the secretion of IgM. It indicates that the responsibility of IL-21 for Ig production may be stronger in RA patients. Through microarray analysis we found many inflammatory factors levels were upregulated in serum from RA patients, suggesting an inflammatory microenvironment in RA. Among these elevated cytokines, IL-2, IL-4, IL-6, IL-7 and IL-10 are all critical for B cell survival and differentiation [
39‐
43]. We speculate that these cytokines might also play important roles in regulating B cell function in RA, and under this inflammatory microenvironment, IL-21 is prone to inducing B cell activation, expansion and differentiation.
IL-21 has been implicated in autoimmunity disease via the IL-21R pathway. Jang
et al. addressed the theory that IL-21R deficiency in the K/BxN mouse model of inflammatory arthritis was sufficient to protect it from arthritis [
29]. Blocking the IL-21 pathway with IL-21R-Fc fusion protein has been shown to ameliorate the clinical and histologic signs of arthritis and dramatically reduce total IgG1 and inflammatory cytokines levels [
44]. Similarly, IL-21R-deficient BXSB.B6-Yaa+/J mice presented none of the abnormal characteristics of systemic lupus erythematosus (SLE) in IL-21R-competent
Yaa mice, including hypergammaglobulinemia, auto-antibody production and reduced frequencies of marginal zone B cells [
45]. Blockade of IL-21 with IL-21R-Fc fusion protein has resulted in fewer IgG glomerular deposits, circulating dsDNA auto-antibodies, total sera IgG1, IgG2a and lymphadenopathy in the lupus-prone MRL-Fas
lpr mouse [
46]. Corresponding to therapeutic efficacy, administration of IL-21R-Fc fusion protein to BXSB.B6-Yaa+/J mice, another model of lupus, decreased lymphocyte activation and circulating IgG1 levels [
47]. In our study, IL-21 induced B cell activation and proliferation could be reversed by anti-IL-21R antibody, which may indicate that IL-21 regulates B cell function via binding with IL-21R.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
XL and LYS designed and directed the research. RL performed the experiments, analyzed and interpreted data and drafted the manuscript. QW, DLS and LYG collected the data. WJC, NC, HFC, and JYC provided critical input and edited the manuscript. All authors read and approved the final manuscript for publication.